Browse press releases
The newest releases come first, each with its full text here and a link to its original. Try the filters to narrow them down.
- Viatris Inc.Viatris Receives U.S. FDA Approval for RYZUMVI® for the Treatment of PresbyopiaCompanies: ViatrisViatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that the U.S. Food and Drug Administration (FDA) has approved RYZUMVI® (phentolamine ophthalmic solution 0.75%) for the treatment of presbyopia in adults. RYZUMVI is...
- Viatris Inc.Viatris Recognized by Forbes as One of the World's Best Employers for the Sixth Consecutive YearCompanies: ViatrisViatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced it was named to Forbes' World's Best Employers list for the sixth consecutive year. The ranking is presented by Forbes and Statista, the world-leading statistics portal and...